Colleen Tupper

Präsident bei DYAX CORP.

Vermögen: 1 Mio $ am 30.04.2024

48 Jahre

43 Beziehungen

Health Technology

Consumer Services

Distribution Services

Aktive Positionen von Colleen Tupper

Unternehmen	Position	Beginn	Ende
DYAX CORP.	Direktor/Vorstandsmitglied	-	-
	Präsident	-	-
	Treasurer	-	-
COLLEGIUM PHARMACEUTICAL, INC.	Finanzdirektor/CFO	24.05.2021	-
BIODELIVERY SCIENCES INTERNATIONAL, INC.	Finanzdirektor/CFO	22.03.2022	-
Shire US, Inc. Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA.	Direktor/Vorstandsmitglied	-	-
	Präsident	-	-
	Treasurer	-	-

Karriereverlauf von Colleen Tupper

Ehemalige bekannte Positionen von Colleen Tupper

Unternehmen	Position	Beginn	Ende
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Corporate Officer/Principal	01.01.2019	01.04.2021
BAXALTA INC	Präsident	-	-

Ausbildung von Colleen Tupper

Franklin Pierce University

Undergraduate Degree

Statistik

International

Vereinigte Staaten

Operativ

President	3
Director/Board Member	2
Treasurer	2

Sektoral

Health Technology	6
Consumer Services	2
Distribution Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	1
COLLEGIUM PHARMACEUTICAL, INC.	Health Technology

Private Unternehmen	5
Dyax Corp. Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA.	Health Technology
Baxalta, Inc. Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.	Health Technology
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Health Technology
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.	Health Technology
Shire US, Inc. Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA.	Distribution Services

Sehen Sie sich die Unternehmensverbindungen an